Globe Clotrimazole Cream USP — Class II drug recall D-0211-2026
Ongoing recall by Blossom Pharmaceuticals, reported 2025-12-10, distributed nationwide. cGMP deviations
| Recall number | D-0211-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Blossom Pharmaceuticals, Bardej, Goa, India |
| Recall initiated | 2025-10-31 |
| Classified | 2025-12-02 |
| Reported by FDA | 2025-12-10 |
| Distributed | Nationwide (US) |
| Quantity | 14,700 bottles |
| Reason classes | cgmp |
| NDC | 69396-0087, 69396-0087-01, 69396-0087-55 |
| Lot numbers | A472418 |
Product
Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, USA, NDC 69396-087-55.
Reason for recall
cGMP deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0211-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.